Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19

Background: Anti-SARS-CoV-2 virus antibody levels in convalescent plasma (CP), which may be useful in severe Anti-SARS-CoV-2 virus infections, have been rarely reported. Results: A total of eight donors were considered for enrollment; two of them were excluded because of ineligible routine check. Of the six remaining participants, five samples were tested weakly positive by the IgM ELISA. Meanwhile, high titers of IgG were observed in five samples. The patient treated with CP did not require mechanical ventilation 11 days after plasma transfusion, and was then transferred to a general ward. Conclusions: Our serological findings in convalescent plasma from recovered patients may help facilitate understanding of the SARS-CoV-2 infection and establish CP donor screening protocol in COVID-19 outbreak. Methods: Anti-SARS-CoV-2 antibodies including IgM and IgG were measured by two enzyme-linked immunosorbent assays (ELISA) in convalescent plasma from six donors who have recovered from coronavirus disease 2019 (COVID-19) in Nanjing, China. CP was also utilized for the treatment of one severe COVID-19 patient.

[1]  Yuan Shi,et al.  Convalescent plasma as a potential therapy for COVID-19 , 2020, The Lancet Infectious Diseases.

[2]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[3]  Yunhui Liu,et al.  Potential interventions for novel coronavirus in China: A systematic review , 2020, Journal of medical virology.

[4]  T. Velavan,et al.  The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.

[5]  P. Horby,et al.  Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans , 2020, Journal of Infection.

[6]  M. Müller,et al.  Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience , 2018, Antiviral therapy.

[7]  Sung‐Han Kim,et al.  Case Report: Use of Plasma Exchange Followed by Convalescent Plasma Therapy in a Critically Ill Patient with Severe Fever and Thrombocytopenia Syndrome-Associated Encephalopathy: Cytokine/Chemokine Concentrations, Viral Loads, and Antibody Responses. , 2018, The American journal of tropical medicine and hygiene.

[8]  Samantha E. Zak,et al.  Anti–Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease , 2018, The Journal of infectious diseases.

[9]  W. Paxton,et al.  Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone , 2018, Transfusion.

[10]  O. Garraud Use of convalescent plasma in Ebola virus infection. , 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[11]  F. Hayden,et al.  Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia , 2016, Emerging infectious diseases.

[12]  Debopam Samanta,et al.  Focal seizure associated with human parvovirus B19 infection in a non-encephalopathic child , 2016, World Journal of Pediatrics.

[13]  Lanjuan Li,et al.  Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[14]  S. Mishra,et al.  Seroprevalence of TORCH infections in antenatal and HIV positive patient populations. , 2015, Medical journal, Armed Forces India.

[15]  W. Lim,et al.  The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.

[16]  Abdulghani Mohamed Alsamarai,et al.  Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq. , 2014, Journal of infection and public health.